NM_001101648.2:c.2547+22C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001101648.2(NPC1L1):c.2547+22C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,613,884 control chromosomes in the GnomAD database, including 21,535 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1580 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19955 hom. )
Consequence
NPC1L1
NM_001101648.2 intron
NM_001101648.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.23
Publications
9 publications found
Genes affected
NPC1L1 (HGNC:7898): (NPC1 like intracellular cholesterol transporter 1) The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NPC1L1 | NM_001101648.2 | c.2547+22C>T | intron_variant | Intron 9 of 18 | ENST00000381160.8 | NP_001095118.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPC1L1 | ENST00000381160.8 | c.2547+22C>T | intron_variant | Intron 9 of 18 | 1 | NM_001101648.2 | ENSP00000370552.3 | |||
| NPC1L1 | ENST00000289547.8 | c.2547+22C>T | intron_variant | Intron 9 of 19 | 1 | ENSP00000289547.4 | ||||
| NPC1L1 | ENST00000546276.5 | c.2547+22C>T | intron_variant | Intron 9 of 17 | 1 | ENSP00000438033.1 |
Frequencies
GnomAD3 genomes AF: 0.125 AC: 18933AN: 152066Hom.: 1579 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18933
AN:
152066
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.133 AC: 33270AN: 250816 AF XY: 0.135 show subpopulations
GnomAD2 exomes
AF:
AC:
33270
AN:
250816
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.159 AC: 231679AN: 1461700Hom.: 19955 Cov.: 34 AF XY: 0.158 AC XY: 114539AN XY: 727162 show subpopulations
GnomAD4 exome
AF:
AC:
231679
AN:
1461700
Hom.:
Cov.:
34
AF XY:
AC XY:
114539
AN XY:
727162
show subpopulations
African (AFR)
AF:
AC:
1213
AN:
33480
American (AMR)
AF:
AC:
3002
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
4539
AN:
26132
East Asian (EAS)
AF:
AC:
133
AN:
39698
South Asian (SAS)
AF:
AC:
9760
AN:
86256
European-Finnish (FIN)
AF:
AC:
12534
AN:
53382
Middle Eastern (MID)
AF:
AC:
712
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
190905
AN:
1111868
Other (OTH)
AF:
AC:
8881
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
10722
21443
32165
42886
53608
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6602
13204
19806
26408
33010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.124 AC: 18926AN: 152184Hom.: 1580 Cov.: 32 AF XY: 0.125 AC XY: 9325AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
18926
AN:
152184
Hom.:
Cov.:
32
AF XY:
AC XY:
9325
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
1709
AN:
41562
American (AMR)
AF:
AC:
1172
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
634
AN:
3466
East Asian (EAS)
AF:
AC:
28
AN:
5178
South Asian (SAS)
AF:
AC:
484
AN:
4824
European-Finnish (FIN)
AF:
AC:
2612
AN:
10578
Middle Eastern (MID)
AF:
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11941
AN:
67962
Other (OTH)
AF:
AC:
223
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
834
1668
2503
3337
4171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.